References
- Kini SP, DeLong LK, Veledar E, et al. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol. 2011;147:1153–1156.
- Chan KY, Li CW, Wong H, et al. Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients. J Palliat Med. 2013;16:966–970.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
- GUPTA MA, GUPTA AK. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticariaa. Ann N Y Acad Sci. 1999;885:394–395.
- Nowicka-Sauer K, Hajduk A, Kujawska-Danecka H, et al. Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus. 2018;27:454–460.
- Bala A, Tue Nguyen HM, Hellstrom WJG. Post-SSRI sexual dysfunction: a literature review. Sex Med Rev. 2018;6(1):29–34.
- FDA Approved Labeling for Zoloft. US Food & Drug Administration. 2017 [cited 2017 Oct 17]; https://www.fda.gov/ohrms/dockets/ac/04/briefing/4006b1_06_zoloft-label.pdf
- FDA Approved Labeling for Paxil. US Food & Drug Administration. 2008. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020031s060,020936s037,020710s024lbl.pdf
- FDA Approved Labeling for Prozac. US Food & Drug Administration. 2009. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018936s075s077lbl.pdf
- FDA Approved Labeling for Luvox. US Food & Drug Administration. 2008. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022235lbl.pdf
- Mayo MJ, Handem I, Saldana S, et al. Sertraline as a first- line treatment for cholestatic pruritus. Hepatology. 2007;45:666–674.
- Zylicz Z, Krajnik M, Sorge AA, et al. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26:1105–1112.
- Stander S, Bockenholt B, Schurmeyer-Horst F, et al. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labeled, two-arm proof-of-concept study. Acta Derm Venereol. 2009;89:45–51.
- Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2003;98:2736–2741.
- Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage. 1998;16:121–124.
- Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera–associated pruritus. Blood. 2002;99:2627.
- Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a Case of Psychogenic Pruritus and Neurotic Excoriations. Psychother Psychosom. 2000;69:165–166.